Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sapanisertib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase
    Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase

    17 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240717288408/en

    BUSINESSWIRE
    17 Jul 2024
    Share Share
    Calithera Receives FDA Fast Track Designation for Sapanisertib
    Calithera Receives FDA Fast Track Designation for Sapanisertib

    03 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/03/2526655/0/en/Calithera-Receives-FDA-Fast-Track-Designation-for-Sapanisertib-for-the-Treatment-of-NRF2-mutated-Squamous-Lung-Cancer.html

    GLOBENEWSWIRE
    03 Oct 2022
    Share Share
    Calithera Biosciences Reports Second Quarter 2022 Financial Results
    Calithera Biosciences Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/15/2498526/32478/en/Calithera-Biosciences-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    15 Aug 2022
    Share Share
    Calithera Bio Shares Progress in Sapanisertib and Mivavotinib Clinical Programs
    Calithera Bio Shares Progress in Sapanisertib and Mivavotinib Clinical Programs

    13 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/13/2479319/32478/en/Calithera-Biosciences-Shares-Progress-in-Sapanisertib-and-Mivavotinib-Clinical-Programs-at-Upcoming-Lung-Cancer-and-Lymphoma-Conferences.html

    GLOBENEWSWIRE
    13 Jul 2022
    Share Share
    Calithera Bio Begins Dosing in PII Trial of Sapanisertib in r/r NRF2-msNSCLC
    Calithera Bio Begins Dosing in PII Trial of Sapanisertib in r/r NRF2-msNSCLC

    06 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/06/2475432/32478/en/Calithera-Biosciences-Announces-First-Patient-Enrolled-in-Phase-2-Clinical-Trial-of-Sapanisertib-in-Relapsed-Refractory-NRF2-NFE2L2-Mutated-Squamous-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    06 Jul 2022
    Share Share
    Struggling Calithera nabs 2 cheap cancer assets from Takeda
    Struggling Calithera nabs 2 cheap cancer assets from Takeda

    20 Oct 2021

    // THEPHARMALETTER

    https://www.thepharmaletter.com/article/two-new-drugs-add-harmony-to-calithera-s-precision-pipeline?__cf_chl_jschl_tk__=pmd_x66vxwinkDHJdlA02hF8AvCwosLXtWK1gLCV4NmksrM-1634712524-0-gqNtZGzNApCjcnBszQs9

    THEPHARMALETTER
    20 Oct 2021
    Share Share